Data / Form D filings / LIMERICK BIOPHARMA INC
LIMERICK BIOPHARMA INC: Form D filings
LIMERICK BIOPHARMA INC, a pharmaceuticals company in San Francisco, CA, filed 7 Form D notices with the SEC between 2009 and 2012. The latest, on January 30, 2012, reports $480,000 sold of a $480,000 offering to 5 investors.
Find out what LIMERICK BIOPHARMA INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 181 28TH AVENUE, San Francisco, CA, 94121
- Phone
- (650) 742-0110
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- California
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1358877
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 30, 2012 | New notice | $480,000 | $480,000 | $0 | 5 | Jan 5, 2012 | sec.gov |
| Jul 26, 2011 | Amendment | $13,228,591 | $9,939,415 | $3,289,176 | 13 | Nov 3, 2010 | sec.gov |
| Mar 10, 2011 | Amendment | $6,935,000 | $6,889,415 | $45,585 | 13 | Nov 3, 2010 | sec.gov |
| Dec 20, 2010 | New notice | $3,585,000 | $3,585,000 | $0 | 13 | Nov 3, 2010 | sec.gov |
| Aug 20, 2009 | Amendment | $15,380,000 | $15,380,000 | $0 | 17 | Jul 14, 2009 | sec.gov |
| Jul 16, 2009 | New notice | $15,150,000 | $15,000,000 | $150,000 | 7 | Jul 14, 2009 | sec.gov |
| Jun 5, 2009 | New notice | $1,500,000 | $1,500,000 | $0 | 5 | Jun 1, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Corey Goodman | Director | |
| Wendye Robbins | Executive Officer, Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jan 30, 2012 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what LIMERICK BIOPHARMA INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.